Blueshift Asset Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Blueshift Asset Management’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-42,393	Closed	-$256K	–	825
2019 Q4	$256K	Buy	+42,393	New	+$245K	0.03%	653

Blueshift Asset Management's ACHN Position: Q1 2020 in Review

Blueshift Asset Management sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 42,393 shares — an estimated $256K sold.

Blueshift Asset Management first reported a position in ACHN in Q4 2019 and held it in 1 quarter. The position peaked at $256K in Q4 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

Blueshift Asset Management reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Blueshift Asset Management sold 42,393 Achillion Pharmaceuticals shares in Q1 2020, an estimated $256K.
Blueshift Asset Management first reported a position in Achillion Pharmaceuticals in Q4 2019 and held it in 1 quarter.
Blueshift Asset Management's Achillion Pharmaceuticals position peaked at $256K in Q4 2019.
0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Blueshift Asset Management's 13F filing for Q1 2020, filed 14 May 2020.